Pouratian N, Schiff D. Management of low-grade glioma[J]. Curr Neurol Neurosci Rep, 2010, 10(3): 224-231.
[2]
Nicolato A, Gerosa MA, Fina P, et al. Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients[J]. Surg Neurol, 1995, 44(3): 208-223.
[3]
Chang EF, Clark A, Jensen RL, et al. Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System[J]. J Neurosurg, 2009, 111(2): 203-210.
Zalutsky MR, Zhao XG, Alston KL, et al. High-level production of alpha-particle-emitting (211) At and preparation of (211) At-labeled antibodies for clinical use[J]. J Nucl Med, 2001, 42(10): 1508-1515.
Wisoff JH, Boyett JM, Berger MS, et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children’s Cancer Group trial no. CCG-945[J]. J Neurosurg, 1998, 89(1): 52-59.
[8]
Aghi MK, Carter BS, Cosgrove GR, et al. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation[J]. Neurosurgery, 2009, 64(1): 56-60.
[9]
Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma[J]. J Clin Oncol, 2002, 20(8): 2076-2084.
[10]
Hartmann C, Hentschel B, Wick W, et al. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas[J]. Acta Neuropathologica, 2010, 120(6): 707-718.
[11]
Scerrati M, Roselli R, Iacoangeli M, et al. Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery[J]. J Neurol Neurosurg Psychiatry, 1996, 61(3): 291-296.
[12]
Shaw EG, Berkey B, Coons SW, et al. Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial[J]. J Neurosurg, 2008, 109(5): 835-841.
[13]
Trojanowski T, Peszynski J, Turowski K, et al. Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy[J]. J Neurosurg, 1989, 70(1): 18-23.
[14]
Rezvan A, Christine D, Christian H, et al. Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients[J]. Acta Neurochir, 2009, 151(11): 1359-1365.
[15]
Rudà R, Trevisan E, Soffietti R. Epilepsy and brain tumors[J]. Currt Opin Oncol, 2010, 22(6): 611-620.
[16]
Mainio A, Hakko H, Niemel A, et al. Gender difference in relation to depression and quality of life among patients with a primary brain tumor[J]. Eur Psychiatry, 2006, 21(3): 194-199.
[17]
Houillier C, Mokhtari K, Carpentier C, et al. Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas[J]. Neuro Oncol, 2010, 12(1): 2-6.
[18]
Hartmann C, Meyer J, Balss J, et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1, 010 diffuse gliomas[J]. Acta Neuropathologica, 2009, 118(4): 469-474.
